156 related articles for article (PubMed ID: 37812494)
21. Tracking Stem Cell Implants in Cartilage Defects of Minipigs by Using Ferumoxytol-enhanced MRI.
Theruvath AJ; Nejadnik H; Lenkov O; Yerneni K; Li K; Kuntz L; Wolterman C; Tuebel J; Burgkart R; Liang T; Felt S; Daldrup-Link HE
Radiology; 2019 Jul; 292(1):129-137. PubMed ID: 31063081
[TBL] [Abstract][Full Text] [Related]
22. Repurposing Ferumoxytol as a Breast Cancer-Associated Macrophage Tracer with Five-Dimensional Quantitative [Fe]MRI of SPION Dynamics.
Sillerud LO; Neuwelt AJ; Staquicini FI; Arap W; Pasqualini R
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359704
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Three Ultrasmall, Superparamagnetic Iron Oxide Nanoparticles for MRI at 3.0 T.
Colbert CM; Ming Z; Pogosyan A; Finn JP; Nguyen KL
J Magn Reson Imaging; 2023 Jun; 57(6):1819-1829. PubMed ID: 36250695
[TBL] [Abstract][Full Text] [Related]
24. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
[TBL] [Abstract][Full Text] [Related]
25. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K;
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792
[TBL] [Abstract][Full Text] [Related]
26. Multimodal In Vivo Tracking of Chimeric Antigen Receptor T Cells in Preclinical Glioblastoma Models.
Wu WE; Chang E; Jin L; Liu S; Huang CH; Kamal R; Liang T; Aissaoui NM; Theruvath AJ; Pisani L; Moseley M; Stoyanova T; Paulmurugan R; Huang J; Mitchell DA; Daldrup-Link HE
Invest Radiol; 2023 Jun; 58(6):388-395. PubMed ID: 36729074
[TBL] [Abstract][Full Text] [Related]
27. Ultrasmall Superparamagnetic Iron Oxide Imaging Identifies Tissue and Nerve Inflammation in Pain Conditions.
Shen S; Ding W; Ahmed S; Hu R; Opalacz A; Roth S; You Z; Wotjkiewicz GR; Lim G; Chen L; Mao J; Chen JW; Zhang Y
Pain Med; 2018 Apr; 19(4):686-692. PubMed ID: 29177411
[TBL] [Abstract][Full Text] [Related]
28. Translatable Drug-Loaded Iron Oxide Nanophore Sensitizes Murine Melanoma Tumors to Monoclonal Antibody Immunotherapy.
Stater EP; Morcos G; Isaac E; Ogirala A; Hsu HT; Longo VA; Grimm J
ACS Nano; 2023 Apr; 17(7):6178-6192. PubMed ID: 36971591
[TBL] [Abstract][Full Text] [Related]
29. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
30. Tumor protease-activated theranostic nanoparticles for MRI-guided glioblastoma therapy.
Huang CH; Chang E; Zheng L; Raj JGJ; Wu W; Pisani LJ; Daldrup-Link HE
Theranostics; 2023; 13(6):1745-1758. PubMed ID: 37064879
[No Abstract] [Full Text] [Related]
31. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO
Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428
[TBL] [Abstract][Full Text] [Related]
32. Iron-oxide-based twin nanoplates with strong T
Wei R; Zhou T; Sun C; Lin H; Yang L; Ren BW; Chen Z; Gao J
Nanoscale; 2018 Oct; 10(38):18398-18406. PubMed ID: 30256373
[TBL] [Abstract][Full Text] [Related]
33. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Kwak K; Yu B; Mouli SK; Larson AC; Kim DH
J Vasc Interv Radiol; 2020 Oct; 31(10):1697-1705.e3. PubMed ID: 32773247
[TBL] [Abstract][Full Text] [Related]
34. Macrophage uptake switches on OCT contrast of superparamagnetic nanoparticles for imaging of atherosclerotic plaques.
Ariza de Schellenberger A; Poller WC; Stangl V; Landmesser U; Schellenberger E
Int J Nanomedicine; 2018; 13():7905-7913. PubMed ID: 30538467
[TBL] [Abstract][Full Text] [Related]
35. Enhanced primary tumor delineation in pancreatic adenocarcinoma using ultrasmall super paramagnetic iron oxide nanoparticle-ferumoxytol: an initial experience with histopathologic correlation.
Hedgire SS; Mino-Kenudson M; Elmi A; Thayer S; Fernandez-del Castillo C; Harisinghani MG
Int J Nanomedicine; 2014; 9():1891-6. PubMed ID: 24790431
[TBL] [Abstract][Full Text] [Related]
36. CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer.
Michaels AD; Newhook TE; Adair SJ; Morioka S; Goudreau BJ; Nagdas S; Mullen MG; Persily JB; Bullock TNJ; Slingluff CL; Ravichandran KS; Parsons JT; Bauer TW
Clin Cancer Res; 2018 Mar; 24(6):1415-1425. PubMed ID: 29288236
[No Abstract] [Full Text] [Related]
37. Editorial for "IOP Injection, A Novel Superparamagnetic Iron Oxide Particle MRI Contrast Agent for the Detection of Hepatocellular Carcinoma: A Phase II Clinical Trial".
Coll-Font J; Nguyen C
J Magn Reson Imaging; 2023 Oct; 58(4):1189-1190. PubMed ID: 36820512
[No Abstract] [Full Text] [Related]
38. Magnetic resonance imaging contrast-enhancement with superparamagnetic iron oxide nanoparticles amplifies macrophage foam cell apoptosis in human and murine atherosclerosis.
Segers FME; Ruder AV; Westra MM; Lammers T; Dadfar SM; Roemhild K; Lam TS; Kooi ME; Cleutjens KBJM; Verheyen FK; Schurink GWH; Haenen GR; van Berkel TJC; Bot I; Halvorsen B; Sluimer JC; Biessen EAL
Cardiovasc Res; 2023 Jan; 118(17):3346-3359. PubMed ID: 35325057
[TBL] [Abstract][Full Text] [Related]
39. Magnetic Particle Imaging of Macrophages Associated with Cancer: Filling the Voids Left by Iron-Based Magnetic Resonance Imaging.
Makela AV; Gaudet JM; Schott MA; Sehl OC; Contag CH; Foster PJ
Mol Imaging Biol; 2020 Aug; 22(4):958-968. PubMed ID: 31933022
[TBL] [Abstract][Full Text] [Related]
40. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
